Epidarex Exeed
Seeds early-stage life science ventures by developing breakthrough therapeutic research into investable assets
Highlights
- New on EvolcAdded 2026-10-31
About Epidarex Exeed
Epidarex Exeed develops early-stage life science assets into companies, applying drug discovery and project management capabilities to therapeutic opportunities.
The company is based in Edinburgh, United Kingdom. It was founded in 2019.
Product: Drug discovery and project management to develop early-stage life science innovations into investable assets.
Jobs at Epidarex Exeed
No open positions listed right now.
More biotech & pharma companies
Epitopea
Develops off-the-shelf RNA cancer immunotherapies for patients with difficult-to-treat cancersNew on EvolcEpsilogen
Develops antibody-based cancer treatments, including a clinical candidate for ovarian cancerNew on EvolcExtracellular
CDMO for cell-based food, cosmetics and materials products, offering bioprocess development and up to 2,000L manufacturingNew on EvolcSalary transparentExymes
Enzyme-based DNA/RNA extraction reagents and kits for forensic, academic, veterinary and environmental labsYoung companyNew on EvolcF2G
Develops first-in-class antifungal medicines for rare, life-threatening fungal infections in patients with limited optionsNew on EvolcFlyttr
Pest biosecurity platform with sensors, AI decision-support and biological countermeasures for governments and agricultureNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Elementor
- WordPress
- jQuery
